Technical Analysis for RGLS - Regulus Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
0.641 | -0.62% | 0.00 |
RGLS closed down 0.62 percent on Monday, October 14, 2019, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| See historical RGLS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Hammer Candlestick | Bullish | -0.62% | |
| Lizard Bullish | Bullish Day Trade Setup | -0.62% | |
| Wide Bands | Range Expansion | -0.62% | |
| Oversold Stochastic | Weakness | -0.62% | |
| Fell Below 50 DMA | Bearish | -0.42% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/06/2019
- Sector: Healthcare
- Industry: Biotechnology
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs to treat various diseases in the United States. The company utilizes its microRNA product platform to develop anti-miRs, a chemically modified single-stranded oligonucleotides. Its microRNA development candidates target miR-122 in hepatitis C virus infection; miR-21 and miR-221 in hepatocellular carcinoma; miR-21 in kidney fibrosis; miR-33 in atherosclerosis; and miR-10b in glioblastoma. The company has strategic alliances with AstraZeneca AB, GlaxoSmithKline plc, Sanofi, and Alnylam and Isis, as well as a strategic collaboration with Biogen Idec MA Inc. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California.
Biopharmaceutical Diseases Genetics Glioblastoma Regulus Therapeutics Hepatocellular Carcinoma RNA Alnylam Pharmaceuticals Hepatitis C Virus Infection Nucleic Acids Atherosclerosis Microrna
Biopharmaceutical Diseases Genetics Glioblastoma Regulus Therapeutics Hepatocellular Carcinoma RNA Alnylam Pharmaceuticals Hepatitis C Virus Infection Nucleic Acids Atherosclerosis Microrna
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more RGLS news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 3.14 |
| 52 Week Low | 0.5026 |
| Average Volume | 110,310 |
| 200-Day Moving Average | 0.998 |
| 50-Day Moving Average | 0.6671 |
| 20-Day Moving Average | 0.7197 |
| 10-Day Moving Average | 0.6648 |
| Average True Range | 0.0568 |
| ADX | 31.04 |
| +DI | 8.8139 |
| -DI | 23.0043 |
| Chandelier Exit (Long, 3 ATRs ) | 0.6896 |
| Chandelier Exit (Short, 3 ATRs ) | 0.7736 |
| Upper Bollinger Band | 0.8544 |
| Lower Bollinger Band | 0.585 |
| Percent B (%b) | 0.21 |
| BandWidth | 37.432263 |
| MACD Line | -0.0219 |
| MACD Signal Line | -0.0116 |
| MACD Histogram | -0.0103 |
| Fundamentals | Value |
|---|---|
| Market Cap | 66.52 Million |
| Num Shares | 104 Million |
| EPS | -1.53 |
| Price-to-Earnings (P/E) Ratio | -0.42 |
| Price-to-Sales | 450.54 |
| Price-to-Book | 2.98 |
| PEG Ratio | -0.03 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.66 | ||||
| Resistance 3 (R3) | 0.66 | 0.66 | 0.66 | ||
| Resistance 2 (R2) | 0.66 | 0.65 | 0.66 | 0.66 | |
| Resistance 1 (R1) | 0.65 | 0.65 | 0.65 | 0.65 | 0.66 |
| Pivot Point | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Support 1 (S1) | 0.63 | 0.64 | 0.63 | 0.63 | 0.62 |
| Support 2 (S2) | 0.63 | 0.63 | 0.63 | 0.62 | |
| Support 3 (S3) | 0.62 | 0.63 | 0.62 | ||
| Support 4 (S4) | 0.62 |
